1-7 of 7
Ana Alarcon Tomas
Close
Sort by
Journal Articles

CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma

Gustav Cederquist, Javin Schefflein, Sean M. Devlin, Gunjan L Shah, Roni Shouval, Harper Hubbeling, Kathryn R. Tringale, Ana Alarcon Tomas, Beatrice Fregonese, Carla Hajj, Alexander P Boardman, Alejandro Luna De Abia, Magdalena Corona, Giulio cassanello, Parastoo B. Dahi, Richard J. Lin, Paola Ghione, Gilles A. Salles, Miguel-Angel Perales, Maria Lia Palomba, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon S. Imber
Journal: Blood Advances
Blood Adv bloodadvances.2024013393.
https://doi.org/10.1182/bloodadvances.2024013393
Published: 2024
Includes: Supplemental data
Journal Articles

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Michael Scordo, Jessica R. Flynn, Mithat Gonen, Sean M. Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L. Porter, Stephen J. Schuster, Veronika Bachanova, Joseph Maakaron, Richard T. Maziarz, Andy I. Chen, Loretta J. Nastoupil, Joseph P. McGuirk, Olalekan O. Oluwole, Andrew Ip, Lori A. Leslie, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5579–5585.
https://doi.org/10.1182/bloodadvances.2023010302
Published: 2023
Includes: Supplemental data
Journal Articles

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Shakthi T. Bhaskar, Vivek G. Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel-Angel Perales, Ana Alarcon Tomas, Michael R. Bishop, Joseph P. McGuirk, Richard T. Maziarz, Andy I. Chen, Veronika Bachanova, Joseph E. Maakaron, Peter A. Riedell, Olalekan O. Oluwole
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4765–4772.
https://doi.org/10.1182/bloodadvances.2022008937
Published: 2023
Journal Articles

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Clinical Trials & Observations
Richard J. Lin, Soo Jung Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M. Hanley, M. Lia Palomba, Miguel-Angel Perales, Gunjan L. Shah, Parastoo B. Dahi, Michael Scordo, Craig S. Sauter, Connie L. Batlevi, Ana Alarcon Tomas, Roni Shouval, Nicole Lee, Emma A. Pavkovic, Danielle E. Engstler, Jae H. Park, Gilles A. Salles, Sean M. Devlin, Beatriz Korc-Grodzicki, Paul A. Hamlin, Sergio A. Giralt
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3501–3505.
https://doi.org/10.1182/bloodadvances.2023010003
Published: 2023
Includes: Supplemental data
Journal Articles

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Clinical Trials & Observations
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R. Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanova, Loretta J. Nastoupil, Joseph P. McGuirk, Richard T. Maziarz, Olalekan O. Oluwole, Stephen J. Schuster, David L. Porter, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3192–3198.
https://doi.org/10.1182/bloodadvances.2022008294
Published: 2023
Includes: Supplemental data
Journal Articles

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT

Roni Shouval, Joshua A. Fein, Christina Cho, Scott T. Avecilla, Josel Ruiz, Ana Alarcon Tomas, Miriam Sanchez-Escamilla, Nerea Castillo Flores, Lucrecia Yáñez, Juliet N. Barker, Parastoo Dahi, Sergio A. Giralt, Alexander I. Geyer, Boglarka Gyurkocza, Ann A. Jakubowski, Richard J. Lin, Richard J. O’Reilly, Esperanza B. Papadopoulos, Ioannis Politikos, Doris M. Ponce, Craig S. Sauter, Michael Scordo, Brian Shaffer, Gunjan L. Shah, James P. Sullivan, Roni Tamari, Marcel R. M. van den Brink, James W. Young, Arnon Nagler, Sean Devlin, Avichai Shimoni, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1525–1535.
https://doi.org/10.1182/bloodadvances.2021004319
Published: 2022
Includes: Supplemental data
Journal Articles

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Clinical Trials & Observations
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R. Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Sean M. Devlin, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Jae H. Park, Lucrecia Yanez San Segundo, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3397–3406.
https://doi.org/10.1182/bloodadvances.2020003885
Published: 2021
Includes: Supplemental data